Have a personal or library account? Click to login
Duration of Anticoagulation Therapy in Patients with Genetic Inherited Thrombophilia Cover

Duration of Anticoagulation Therapy in Patients with Genetic Inherited Thrombophilia

PRILOZI
Volume 43 (2022): Issue 2 (July 2022)
By: Ivica Bojovski,  Svetlana Stankovic,  Aleksandar Petlichkovski and  Marijan Bosevski  
Open Access
|Jul 2022

Authors

Ivica Bojovski

ivicabojovski@hotmail.com

Ss Cyril and Methodius University, Faculty of Medicine, Skopje, RN Macedonia
University Clinic of Cardiology, RN Macedonia

Svetlana Stankovic

Ss Cyril and Methodius University, Faculty of Medicine, Skopje, RN Macedonia
University Clinic for Hematology, Skopje, RN Macedonia

Aleksandar Petlichkovski

Ss Cyril and Methodius University, Faculty of Medicine, Skopje, RN Macedonia
Institute of Immunobiology and Human Genetics, Skopje, RN Macedonia

Marijan Bosevski

Ss Cyril and Methodius University, Faculty of Medicine, Skopje, RN Macedonia
University Clinic of Cardiology, RN Macedonia
DOI: https://doi.org/10.2478/prilozi-2022-0016 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345
Journal RSS Feed
Language: English
Page range: 33 - 40
Published on: Jul 13, 2022
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
deep vein thrombosis,
pulmonary embolism,
anticoagulation therapy,
genetic investigation,
mutation,
prothrombin,
thrombophilia
Related subjects:
Medicine,
Basic medical science,
History and ethics of medicine,
Clinical medicine,
Clinical medicine, other,
Social sciences,
Education,
Education, other

© 2022 Ivica Bojovski, Svetlana Stankovic, Aleksandar Petlichkovski, Marijan Bosevski, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 43 (2022): Issue 2 (July 2022)Next article